GlassScriptPhysician profile
Luke K Griffiths
NPI 1760945836
$26,873.00
in general payments reported to CMS, 2019-2025
10 companies · $1,102 in 2025
The $1,102 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $26K · 2025: $1,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,873.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25,626.24 | 2024-2025 | Percutaneous Tract Kit, Rezum Generator, General - Kidney Stone Disease |
| Calyxo, INC. | $500.24 | 2025 | Cvac Aspiration System |
| Janssen Biotech, INC. | $146.21 | 2025 | Carvykti, Rybrevant |
| Cook Medical LLC | $145.20 | 2024 | Litho 150 |
| Ambu INC. | $143.77 | 2025 | |
| Caldera Medical, INC | $137.04 | 2024 | Desara |
| Medtronic, INC. | $103.97 | 2024 | Interstim |
| 180 Medical, INC. | $41.55 | 2025 | Gentlecath Glide |
| Axonics, INC. | $15.32 | 2024 | Bulkamid |
| Coloplast Corp | $13.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Griffiths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.